Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC
(ID 40)
Industry Satellite Symposium
Calendar Export
How may we overcome resistance to CPI therapy?
Lecture Time
11:55 - 12:15
Speakers
S. Popat
(London, United Kingdom)
Authors
S. Popat
(London, United Kingdom)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC
(ID 40)
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Room
Auditorium 2